Matches in Wikidata for { <http://www.wikidata.org/entity/Q81369631> ?p ?o ?g. }
Showing items 1 to 63 of
63
with 100 items per page.
- Q81369631 description "artículu científicu espublizáu en febreru de 2005" @default.
- Q81369631 description "scientific article published on 02 February 2005" @default.
- Q81369631 description "wetenschappelijk artikel" @default.
- Q81369631 description "наукова стаття, опублікована в лютому 2005" @default.
- Q81369631 name "Long-term follow-up of a randomized trial of fludarabine-mitoxantrone, compared with cyclophosphamide, doxorubicin, vindesine, prednisone (CHVP), as first-line treatment of elderly patients with advanced, low-grade non-Hodgkin's lymphoma before the" @default.
- Q81369631 name "Long-term follow-up of a randomized trial of fludarabine-mitoxantrone, compared with cyclophosphamide, doxorubicin, vindesine, prednisone (CHVP), as first-line treatment of elderly patients with advanced, low-grade non-Hodgkin's lymphoma before the" @default.
- Q81369631 type Item @default.
- Q81369631 label "Long-term follow-up of a randomized trial of fludarabine-mitoxantrone, compared with cyclophosphamide, doxorubicin, vindesine, prednisone (CHVP), as first-line treatment of elderly patients with advanced, low-grade non-Hodgkin's lymphoma before the" @default.
- Q81369631 label "Long-term follow-up of a randomized trial of fludarabine-mitoxantrone, compared with cyclophosphamide, doxorubicin, vindesine, prednisone (CHVP), as first-line treatment of elderly patients with advanced, low-grade non-Hodgkin's lymphoma before the" @default.
- Q81369631 prefLabel "Long-term follow-up of a randomized trial of fludarabine-mitoxantrone, compared with cyclophosphamide, doxorubicin, vindesine, prednisone (CHVP), as first-line treatment of elderly patients with advanced, low-grade non-Hodgkin's lymphoma before the" @default.
- Q81369631 prefLabel "Long-term follow-up of a randomized trial of fludarabine-mitoxantrone, compared with cyclophosphamide, doxorubicin, vindesine, prednisone (CHVP), as first-line treatment of elderly patients with advanced, low-grade non-Hodgkin's lymphoma before the" @default.
- Q81369631 P1433 Q81369631-6F988545-DBCE-436F-BFE1-00FD58F5B300 @default.
- Q81369631 P1476 Q81369631-7CD019AE-46FC-4382-A62C-3C5B2BEB6913 @default.
- Q81369631 P2093 Q81369631-34CC8354-AFD5-41FC-9795-98189E6C15FB @default.
- Q81369631 P2093 Q81369631-34D18490-50E3-4BC3-AB41-786F258821D3 @default.
- Q81369631 P2093 Q81369631-3F8C540E-5410-469F-96B0-32EF5A9BBC94 @default.
- Q81369631 P2093 Q81369631-78835C35-DDD1-4D97-808C-AB1567F8050C @default.
- Q81369631 P2093 Q81369631-9BF79E72-DBE6-4430-82B7-3C50436F24B2 @default.
- Q81369631 P2093 Q81369631-A4F7BB1B-280B-4311-A003-299056C2B639 @default.
- Q81369631 P2093 Q81369631-ACDE798E-4C83-4D81-AA7B-06D680F81D57 @default.
- Q81369631 P2093 Q81369631-AE3C6D82-2B66-4BB8-83B2-F5A6DBF75D3F @default.
- Q81369631 P2093 Q81369631-B996D458-AA94-4BC6-B050-2DD9F384C4D7 @default.
- Q81369631 P2093 Q81369631-C501927A-E717-465F-9DF8-2C1B8DD6449A @default.
- Q81369631 P2093 Q81369631-CA6EA6AD-8724-4FA8-BDF3-8D9C0B8EDF57 @default.
- Q81369631 P2093 Q81369631-D54C7EFC-4D50-443F-A391-154BF05596F3 @default.
- Q81369631 P2093 Q81369631-E14D5907-7B69-4982-B858-A930B5FB2938 @default.
- Q81369631 P2093 Q81369631-FF2F56A3-936A-46BB-A46E-542B0157911E @default.
- Q81369631 P304 Q81369631-02F33371-C2FC-498F-853F-B8974E5BC786 @default.
- Q81369631 P31 Q81369631-BB44F4D1-227B-4A6D-88C3-62FEABDA560B @default.
- Q81369631 P356 Q81369631-589026A6-1558-4B01-AFC4-4D972470F5B5 @default.
- Q81369631 P433 Q81369631-F63FA61A-C2C6-4E2B-B05B-DEABD281F29A @default.
- Q81369631 P478 Q81369631-51575342-9C79-4A5E-82EE-65FF4B9CED3B @default.
- Q81369631 P50 Q81369631-712BCF80-A86B-49CE-A2A1-A0E94F2AE6B0 @default.
- Q81369631 P577 Q81369631-7096EA6D-72CE-46C1-BB14-DC33259224EC @default.
- Q81369631 P698 Q81369631-A03A8E5A-A9CC-4E24-9C45-313E976DF17B @default.
- Q81369631 P921 Q81369631-11B9103C-79EA-44D2-AA55-A87A73ACCC4F @default.
- Q81369631 P356 MDI091 @default.
- Q81369631 P698 15695500 @default.
- Q81369631 P1433 Q326122 @default.
- Q81369631 P1476 "Long-term follow-up of a randomized trial of fludarabine-mitoxantrone, compared with cyclophosphamide, doxorubicin, vindesine, prednisone (CHVP), as first-line treatment of elderly patients with advanced, low-grade non-Hodgkin's lymphoma before the era of monoclonal antibodies" @default.
- Q81369631 P2093 "B Desablens" @default.
- Q81369631 P2093 "B Mahé" @default.
- Q81369631 P2093 "B Pignon" @default.
- Q81369631 P2093 "C Berthou" @default.
- Q81369631 P2093 "C Foussard" @default.
- Q81369631 P2093 "C Ghandour" @default.
- Q81369631 P2093 "E Deconinck" @default.
- Q81369631 P2093 "H Maisonneuve" @default.
- Q81369631 P2093 "M-C Rousselet" @default.
- Q81369631 P2093 "P Casassus" @default.
- Q81369631 P2093 "P Colombat" @default.
- Q81369631 P2093 "P Rachieru" @default.
- Q81369631 P2093 "T Lamy" @default.
- Q81369631 P2093 "V Delwail" @default.
- Q81369631 P304 "466-472" @default.
- Q81369631 P31 Q13442814 @default.
- Q81369631 P356 "10.1093/ANNONC/MDI091" @default.
- Q81369631 P433 "3" @default.
- Q81369631 P478 "16" @default.
- Q81369631 P50 Q62669287 @default.
- Q81369631 P577 "2005-02-02T00:00:00Z" @default.
- Q81369631 P698 "15695500" @default.
- Q81369631 P921 Q18936 @default.